research-articleIndian Journal of Pharmaceutical Education and ResearchVol. 58 | Issue 2s | 2024 | pp. s444–s452Open access
Quality by Design (QbD) Aided Formulation Optimization of Amlodipine Besylate Oral Thin Film
- 1,
- 2,
- 3,
- 4,
- 1*ORCID
- 1 Esperer Nutrition Development Center, Esperer Onco Nutrition Private Limited, Mumbai, Maharashtra, INDIA.
- 2 Department of Pharmaceutics, Goel Institute of Pharmacy and Sciences, Lucknow, Uttar Pradesh, INDIA.
- 3 Department of Pharmacy, Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, INDIA.
- 4 School of Pharmaceutical Sciences, Sardar Bhagwan Singh University, Dehradun, Uttarakhand, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Anubhab Mukherjee
Esperer Nutrition Development Center, Esperer Onco Nutrition Private Limited, Mumbai, Maharashtra, INDIA.
Email: mukherjeeanubhab1@gmail.com
Copyright: © 2024 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2024
- Received:
- Jul 26, 2023
- Accepted:
- Jan 20, 2024
- DOI:
- 10.5530/ijper.58.2s.48
How to cite
Kumar, A., Kumar, M., Singh, R., Upadhyay, P., & Mukherjee, A. (2024). Quality by Design (QbD) Aided Formulation Optimization of Amlodipine Besylate Oral Thin Film. Indian Journal of Pharmaceutical Education and Research, 58(2s), s444–s452. https://doi.org/10.5530/ijper.58.2s.48
Abstract
Background
Oral Thin Film (OTF) is an emerging approach for oral drug delivery but still there exists a scarcity of evidence for formulation optimization techniques. Herein, we aim to develop OTFs optimized by the QbD approach.
Materials and Methods
OTFs were prepared by solvent casting method using Amlodipine as an active ingredient and excipients such as Pectin, Aspartame, Tween 80, and Glycerine. The developed formulation was optimized using QbD software Design Expert version 8.0.4, USA. The independent variables of the experiment were selected as A-pectin, B-Tween-80, and C-glycerine, and the dependent variables were R1-tensile strength (kg/cm2), R2-permeation rate (μg/cm2/hr), R3-disintegration time (in a sec). Finally, the software suggested optimized formulation based on a desirability value closer to 1.
Results
The optimized oral films were comparatively evaluated and characterized by various techniques. The drug release was found to be ~96% at 10 min for OTFs and ~94% at 20 min for oral fast-dissolving tablets. The amlodipine was scanned in the UV range of 200 to 400 nm and the λmax was observed to be at 240±2 in a Phosphate of pH 6.8.
Conclusion
All results are found satisfactory and well within the acceptance range. This ensures that similar formulations can be optimized by using this technique in the future.
Keywords
Subject
Article metadata
| Title | Quality by Design (QbD) Aided Formulation Optimization of Amlodipine Besylate Oral Thin Film |
|---|---|
| Authors | Abhiram Kumar; Madhaw Kumar; Romi Singh; Pratibha Upadhyay; Anubhab Mukherjee |
| Affiliations | Esperer Nutrition Development Center, Esperer Onco Nutrition Private Limited, Mumbai, Maharashtra, INDIA.; Department of Pharmaceutics, Goel Institute of Pharmacy and Sciences, Lucknow, Uttar Pradesh, INDIA.; Department of Pharmacy, Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, INDIA.; School of Pharmaceutical Sciences, Sardar Bhagwan Singh University, Dehradun, Uttarakhand, INDIA. |
| Corresponding author | mukherjeeanubhab1@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 58, Issue 2s (2024) |
Also in this issue
- Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysispp. s332–s339
- Effectiveness of Complementary and Alternative Medicine and Physical Therapies in Peripheral Arterial Disease with Intermittent Claudication: A Systematic Reviewpp. s340–s353
- Implementation of National Education Policy 2020 in Pharmacy Educationpp. s354–s358
- A Biochemical and Molecular Insight to Wound Healing Properties of Traditional Indian Medicines in Normal and Diabetic Ratspp. s359–s371
- Chlorogenic Acid, a Potential Glucose-6-Phosphatase Inhibitor: An Approach to Develop a Pre-Clinical Glycogen Storage Disease Type I Modelpp. s372–s381